325 related articles for article (PubMed ID: 7711130)
21. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
[TBL] [Abstract][Full Text] [Related]
22. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
[TBL] [Abstract][Full Text] [Related]
23. Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients.
Troya J; Casquero A; Refoyo E; Fernández-Guerrero ML; Górgolas M
Scand J Infect Dis; 2008; 40(1):78-80. PubMed ID: 17852921
[TBL] [Abstract][Full Text] [Related]
24. Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani.
Albrecht H; Sobottka I; Emminger C; Jablonowski H; Just G; Stoehr A; Kubin T; Salzberger B; Lutz T; van Lunzen J
Arch Pathol Lab Med; 1996 Feb; 120(2):189-98. PubMed ID: 8712898
[TBL] [Abstract][Full Text] [Related]
25. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
[TBL] [Abstract][Full Text] [Related]
26. [Visceral leishmaniasis in patients with HIV infection. Our experience].
Terra L; Pellicanò S; Allò M
Minerva Med; 1996 Jun; 87(6):317-9. PubMed ID: 8700361
[TBL] [Abstract][Full Text] [Related]
27. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil.
Oliveira RA; Silva LS; Carvalho VP; Coutinho AF; Pinheiro FG; Lima CG; Leandro JE; Silva GB; Daher EF
Transpl Infect Dis; 2008 Oct; 10(5):364-8. PubMed ID: 18507750
[TBL] [Abstract][Full Text] [Related]
28. Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.
Pasquau F; Ena J; Sanchez R; Cuadrado JM; Amador C; Flores J; Benito C; Redondo C; Lacruz J; Abril V; Onofre J;
Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):411-8. PubMed ID: 15928908
[TBL] [Abstract][Full Text] [Related]
29. [Concurrent leishmaniasis and human immunodeficiency virus (HIV) infection: a study of four cases].
Borges AS; Machado AA; Ferreira MS; de Castro Figueiredo JF; Silva GF; Cimerman S; Bacha HA; Teixeira MC
Rev Soc Bras Med Trop; 1999; 32(6):713-9. PubMed ID: 10881110
[TBL] [Abstract][Full Text] [Related]
30. [Visceral leishmaniasis in patient with HIV infection].
Olea P; Pinilla J
Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
[TBL] [Abstract][Full Text] [Related]
31. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
Dursun O; Erişir S; Yeşilipek A
Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
[TBL] [Abstract][Full Text] [Related]
32. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Patel TA; Lockwood DN
Trop Med Int Health; 2009 Sep; 14(9):1064-70. PubMed ID: 19552658
[TBL] [Abstract][Full Text] [Related]
33. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN
Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852
[TBL] [Abstract][Full Text] [Related]
34. [Visceral leishmaniasis and HIV infection: the diagnostic and therapeutic problems].
Rocha PS; Rebocho L; Alvoeiro L; Lourenço G; Branco R; Victorino RM; de Moura MC
Acta Med Port; 1993 Nov; 6(11):543-6. PubMed ID: 8140923
[TBL] [Abstract][Full Text] [Related]
35. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.
d'Ettorre G; Ceccarelli G; Carnevalini M; Forcina G; Zaffiri L; Massetti AP; Mastroianni CM; Vullo V
Acta Trop; 2006 Aug; 99(1):83-7. PubMed ID: 16962979
[TBL] [Abstract][Full Text] [Related]
36. Visceral leishmaniasis in HIV-infected patients in the south of France.
Dereure J; Reynes J; Pratlong F; Lamaury I; Rioux JA; Janbon F; Dedet JP
Bull World Health Organ; 1995; 73(2):245-6. PubMed ID: 7743597
[TBL] [Abstract][Full Text] [Related]
37. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
38. Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001).
Pagliano P; Rossi M; Rescigno C; Altieri S; Coppola MG; Gramiccia M; Scalone A; Gradoni L; Faella F
J Antimicrob Chemother; 2003 Aug; 52(2):264-8. PubMed ID: 12865389
[TBL] [Abstract][Full Text] [Related]
39. [Visceral leishmaniasis located in the intestines in patients with human immunodeficiency virus infection: a report of 2 cases].
Roig P; Cuadrado JM; Benéitez C; Mayol MJ; López M; Navarro V; Nieto A; Bernacer B
Rev Clin Esp; 1993 Apr; 192(6):271-3. PubMed ID: 8497722
[TBL] [Abstract][Full Text] [Related]
40. [The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection].
Macías J; Pineda JA; Gallardo JA; Lissen E
Med Clin (Barc); 1999 Feb; 112(4):157. PubMed ID: 10074637
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
